Dr. Christopher D. Streib, MD
Neurology (Neurology Physician)
- Medicare participating
At a glance
- Medical school
- University of Iowa, Rj & L Carver College of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 105
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: University of Iowa, Rj & L Carver College of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
MN license 59820 · PA license MT193228
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- M Health Fairview University of Mn Medical Center Minneapolis, MN
- M Health Fairview Southdale Hospital Edina, MN
Medical groups
- Fairview Express Care (1,911 clinicians)
- Healtheast Medical Research Institute (649 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 105
- Services billed
- 210
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 86 | 49 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 49 | 31 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 48 | 34 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 25 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 19 | 19 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 15 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 2 companies reported 2 payments worth $5,799 in total to this clinician.
| Genentech USA, Inc. | $5,650 |
|---|---|
| Janssen Research & Development, LLC | $149 |
| Consulting Fee | $5,650 |
|---|---|
| Food and Beverage | $149 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Genentech USA, Inc. Mar 26, 2025 | Consulting Fee TNKase · Metabolism & Primary Care | $5,650 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $458,779 in research payments for these studies, mostly to the institutions running them.
- A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
Janssen Research & Development, LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.